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Ras-independent activation of Ral by a Ca2+-dependent pathway
Franz Hofer, Rebecca Berdeaux and G. Steven Martin
The RalA and RalB proteins comprise a distinct family
of small GTPases [1]. Ral-specific guanine-nucleotide
exchange factors such as RalGDS, Rlf and RGL interact
with activated Ras and cooperate with Ras in the
transformation of murine fibroblasts [2–5]. Thus, the
interaction of RalGDS with Ras and the subsequent
activation of Ral are thought to constitute a distinct
Ras-dependent signaling pathway. The function of Ral
is largely unknown. There is circumstantial evidence
that Ral may have a function in regulating the
cytoskeleton through its interaction with RIP1 (also
known as RLIP or RalBP1), a GTPase-activating protein
specific for the small GTPases Cdc42 and Rac [6–8]. Ral
also binds to phospholipase D (PLD) and thus may play
a role in signaling through phospholipids [9]. We have
examined endogenous levels of activated, GTP-bound
Ral (Ral—GTP) in Rat-2 fibroblasts stimulated with
various mitogens. Lysophosphatidic acid (LPA) and
epidermal growth factor (EGF), which activate both 
Ras-dependent and Ras-independent signaling
pathways [10,11], rapidly activated Ral. Inhibition of Ras
activation by dominant-negative Ras (RasS17N) or
pertussis toxin had little effect on Ral—GTP levels,
however. Ral was activated by the Ca2+ ionophore
ionomycin, and activation by LPA or EGF could be
blocked by a phospholipase C (PLC) inhibitor. The
results presented here demonstrate a Ca2+-dependent
mechanism for the activation of Ral.
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Results and discussion
In order to examine the regulation of Ral in vivo we have
used an affinity precipitation assay for activated Ral. This
assay is based on the ability of GTPase effector proteins to
interact specifically with the activated, GTP-bound form of
the GTPase; this type of assay has been used previously to
assay levels of Ras–GTP [12,13]. We can detect Ral–GTP
in cell lysates by precipitation with a glutathione-S-trans-
ferase (GST) fusion protein containing the Ral-binding
domain of RIP1 [8]. The validity of this assay was tested by
transient transfection assays in COS-7 cells (Figure 1a). Co-
transfection of RalGDS with RalB substantially increased
the amount of precipitated Ral–GTP. As expected, an acti-
vated mutant of RalB (RalBQ72L) was precipitated in signifi-
cantly greater quantities than wild-type RalB, and
expression of a dominant-negative RalB mutant (RalBS28N)
resulted in precipitation of very little Ral–GTP (Figure 1a),
even in the presence of RalGDS. Overexpression of an acti-
vated Ras mutant (RasG12V), however, had very little effect
on the activation of RalB (Figure 1b), and a RalGDS mutant
(RalGDS∆RID) lacking the Ras-interacting domain was
able to activate RalB (Figure 1b). These results suggest that
Ral can be activated by RalGDS, not only by Ras-depen-
dent mechanisms, but also by Ras-independent pathways.
To further characterize the role of Ras in Ral activation we
examined the effect of mitogens on the activation of
endogenous Ral protein in Rat-2 fibroblasts. When cells
were serum-starved for 24 hours and then stimulated with
fetal calf serum (FCS), Ral was rapidly activated; Ral acti-
vation reached a maximum after 2 minutes and returned
close to the pre-stimulation level within 30 minutes
(Figure 2a). Stimulation of quiescent Rat-2 cells with
either LPA or EGF also led to rapid activation of Ral
(Figure 2a) with similar kinetics to those observed with
FCS. Both LPA and EGF have been shown to lead to acti-
vation of Ras in fibroblasts [14,15]. To determine if Ral
activation is Ras-dependent, we examined the effects of
LPA and EGF on a Rat-2 cell line that expresses RasS17N
under the control of the metal-inducible metallothionein
promoter (R2-N17 cells) [16]. The activation state of Ras
was measured by precipitating Ras–GTP with a GST
fusion protein containing the Ras-binding domain of
c-Raf1 [17]. Ras was strongly activated by LPA or EGF in
control Rat-2 cells, but Ras activation could not be
detected in the R2-N17 cells, even when RasS17N was not
induced (Figure 2b and data not shown), indicating that
small amounts of RasS17N are sufficient to inhibit Ras acti-
vation. We have shown previously that the expression of
RasS17N also blocked the induction of Erk2 mitogen-acti-
vated protein (MAP) kinase activity in these cells [16]. In
contrast, both LPA and EGF stimulated Ral activation in
the presence of significant amounts of RasS17N (Figure 2b),
demonstrating that EGF and LPA can induce Ral activa-
tion in the absence of a detectable increase in Ras–GTP.
To determine if active Ras is sufficient to activate endoge-
nous Ral, we used a Rat-2 cell line that expresses activated
RasQ61L under the control of a tetracycline-repressible pro-
moter. Cells were serum starved for 24 hours in the pres-
ence of tetracycline, then washed and further incubated in
serum-free medium without tetracycline to induce
RasQ61L expression. The cells were lysed at intervals and
Ral activation was measured (Figure 2c). Ral was repro-
ducibly activated 8 hours after withdrawal of tetracycline
at times when there was only a modest increase in Ras
expression. Activation of Ral did not increase at later
times, even though expression of RasQ61L continued to
increase. The amount of Ral–GTP returned to back-
ground levels 12 hours after induction, and cells that had
been without tetracycline for 24 hours and expressed sig-
nificant amounts of RasQ61L contained very little
Ral–GTP (Figure 2c). These results indicate that Ras acti-
vation is sufficient to activate Ral, although the level of
Ral–GTP following induction of RasQ61L was considerably
less than that observed with LPA or EGF, and FCS could
activate Ral in cells in which RasQ61L was no longer effec-
tive (Figure 2c). Taken together with the failure of
RasS17N to block Ral activation by these mitogens, these
findings suggest that Ral activation can be mediated by
Ras-independent signaling pathways.
LPA has been shown to stimulate several intracellular sig-
naling pathways via distinct G-protein-coupled receptors.
LPA stimulates Ras–GTP accumulation (and inhibits
adenylyl cyclase) through the pertussis-toxin-sensitive Gi
protein, activates PLC via Gq protein and also signals to the
small GTPase Rho through the G12/13 protein [11]. EGF
activates Ras through the well-characterized Grb2–Sos
pathway [18] and also stimulates PLC activity in some cell
types [19]. PLC in turn generates two second messengers:
inositol 1,4,5-trisphosphate, which releases Ca2+ from inter-
nal stores leading to an increase in intracellular Ca2+, and
diacylglycerol, which is an activator of protein kinase C [10].
To determine the possible role of these second messengers
in Ral activation, we used the Ca2+ ionophore ionomycin to
elevate the concentration of intracellular Ca2+, and the
phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)
to activate protein kinase C [20]. Whereas treatment of qui-
escent Rat-2 cells with ionomycin activated Ral, no effect
was seen for TPA (Figure 3a), indicating that an increase in
intracellular Ca2+ is sufficient to activate Ral.
To determine whether PLC activation can account for the
effects of LPA and EGF on Ral activation, we examined
the effect of U-73122, an inhibitor of agonist-induced PLC
activity [21], on Ral–GTP accumulation triggered by these
mitogens. When serum-starved Rat-2 cells were exposed to
LPA or EGF in the presence or absence of U-73122, the
mitogen-induced increase in Ral–GTP was completely
blocked in cells that had been pre-treated with the PLC
inhibitor (Figure 3b), indicating that PLC activity is neces-
sary for Ral activation by these mitogens. In contrast, when
cells were treated with pertussis toxin to inhibit LPA-
induced activation of Ras [15], accumulation of Ral–GTP
stimulated by LPA was only minimally affected
(Figure 3b). As expected, the PLC inhibitor had little effect
on Ral–GTP levels induced by ionomycin (Figure 3b).
In summary, our results represent a direct demonstration
that Ral can be activated through multiple signaling path-
ways. Our data confirm previous findings that Ral can be
activated by a Ras-dependent signaling pathway [2,3,5]; a
recent report indicates that in NIH3T3 cells Ral activation
by mitogens is Ras-dependent [22]. We extend these 
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Figure 1
The activation of Ral in transfected COS-7
cells. (a) COS-7 cells were transfected with
300 ng RalB, 300 ng RalB plus 50 ng
RalGDS, 300 ng RalBS28N plus 150 ng
RalGDS, or 300 ng RalBQ72L DNA as
indicated, and grown in medium
supplemented with 10% FCS before lysis.
Ral–GTP was precipitated with
glutathione–Sepharose-bound GST–RIP and
both the pellet (upper panel) and supernatant
fractions (lower panel) were analyzed by
immunoblotting with the indicated antibodies.
One representative experiment is shown.
(b) COS-7 cells were transfected with 300 ng
RalB, 50 ng RalGDS, 50 ng RalGDS∆RID
and 50 ng Ha-RasG12V constructs as
indicated and grown in medium containing
serum. Ral–GTP was precipitated as in (a)
and both the pellet and supernatant fractions
were analyzed by immunoblotting. The graph
shows data from five independent
experiments (results are mean values ± SD)
and the western blots are from one
representative experiment.
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findings by showing that in Rat-2 cells Ral can also be 
regulated by a Ras-independent pathway: an increase in 
intracellular Ca2+ due to activation of PLC is a crucial step
in growth-factor induced activation of the Ral GTPases.
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(c)
The effect of mitogens and mutant forms of Ras on the activation of
endogenous Ral. (a) Mitogen-induced activation of Ral in serum-
starved Rat-2 cells. Cells were stimulated with 10% FCS, 100 ng/ml
EGF or 5 µg/ml LPA, and Ral–GTP levels were analyzed at the
indicated times as described for Figure 1. The graph shows data from
two experiments (mean ± SD) and the western blots are from one
representative experiment. (b) Effect of dominant-negative Ras on
mitogen-induced Ral activation. Parental Rat-2 cells or those
expressing RasS17N under the control of the metallothionein promoter
(R2-N17) were serum-starved for 24 h. RasS17N expression was
induced in one set of R2-N17 cells by adding ZnCl2 and CdCl2 to a
final concentration of 20 µM and 0.4 µM, respectively; the other set
were not induced (NI). Cells were then treated with 100 ng/ml EGF,
5 µg/ml LPA or buffer alone (control) for 2 min. Ral–GTP and
Ras–GTP were precipitated with GST–RIP or the Raf GST fusion
protein, respectively, and analyzed by SDS–PAGE and
immunoblotting. The graph shows data from two experiments in cells
stimulated with LPA or EGF (mean ± SD) and the western blots are
from one representative experiment in cells stimulated with LPA.
(c) Rat-2 cells expressing the activated RasQ61L mutant under control
of a tetracycline-repressible promoter (R2tTA-Q61L) were serum-
starved for 24 h in the presence of tetracycline, washed twice with
PBS and incubated in serum-free medium without tetracycline to
induce RasQ61L expression. Cells were lysed at the indicated times
after the removal of tetracycline and Ral–GTP was assayed. The FCS
stimulation at 24 h was for 2 min at 10%. The graph shows data from
three experiments (mean ± SD) and the western blots are from one
representative experiment.
Figure 3
The role of Ca2+ in the activation of
endogenous Ral. (a) The effect of ionomycin
and TPA on the activation of Ral in serum-
starved Rat-2 cells. Cells were stimulated
with 0.5 µg/ml ionomycin (iono) or 100 ng/ml
TPA, and Ral–GTP was assayed at the
indicated times. The graph shows data from
two experiments (mean ± SD) and the
western blots are from one representative
experiment. (b) The effect of the PLC
inhibitor U-73122 or pertussis toxin (PTX) on
Ral activation. Rat-2 cells were serum-starved
for 24 h and then incubated with U-73122
(10 µM) for 5 min, with pertussis toxin
(1 µg/ml) for 2 h or with DMSO for 5 min (no
inhibitor). Cells were stimulated with 5 µg/ml
LPA, 100 ng/ml EGF, 0.5 µg/ml ionomycin or
vehicle alone (C). Endogenous Ral–GTP and
Ras–GTP levels were assayed as described
in the legends to Figures 1 and 2. The graph
shows data from three experiments
(mean ± SD) and the western blots are from
one representative experiment.
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While this paper was under review, Wolthuis et al. [23]
reported that activation of Ral in platelets is Ca2+-depen-
dent and does not correlate with Ras activation. Mecha-
nisms that might mediate the effect of Ca2+ on Ral
activation include the phosphorylation of RalGDS by the
multifunctional Ca2+–calmodulin-dependent kinase II
(CaMK-II) or the direct interaction of Ca2+–calmodulin with
Ral [24]. Thus, Ral represents a potential site for integration
of Ras-dependent and Ras-independent signaling pathways.
Materials and methods
Cell culture and transfections
All cell lines were cultured in F10/DME (2:1) supplemented with 10%
(volume : volume) FCS. COS-7 cells (1 × 106 cells per 6 cm dish) were
transiently transfected using the Lipofectamine reagent (GIBCO)
according to the recommendations of the manufacturer. Rat-2 cells
were seeded into 10 cm dishes at 50% confluency and grown
overnight in standard medium (10% FCS). Cells were then serum
starved for 24 h in F10/DME containing 20 mM Hepes buffer pH 7.4
(Hepes was used to minimize pH fluctuations during the subsequent
mitogen treatment). Cells were stimulated at room temperature by
adding mitogens from concentrated stocks directly to the medium;
control unstimulated cells received an equal volume of the appropriate
vehicle (10 mM acetic acid containing 1 mg/ml bovine serum albumin
(BSA) for EGF; PBS containing 1 mg/ml BSA for LPA; and DMSO for
ionomycin and TPA). The cells were incubated at room temperature for
a maximum of 3 min, and, when longer stimulation times were required,
the cells were returned to the incubator until lysis.
Ral–GTP and Ras–GTP precipitation assays
After transfection or mitogen treatment, cells were washed twice in ice-
cold PBS and lysed in 0.5 ml (COS-7 cells) or 1 ml (Rat-2 cells) ice-cold
lysis buffer (50 mM Tris.HCl pH 7.5, containing 150 mM NaCl, 20 mM
MgCl2, 1% NP-40 and protease inhibitors). Samples were adjusted to
the same protein concentration in a final volume of 0.5 ml or 1 ml. GST
fusion proteins (6 µg of GST–RIP or 10 µg of the Raf GST fusion
protein) adsorbed to glutathione–Sepharose beads were added and
incubated for 2 h at 4°C with mixing. Samples of the supernatants (1/10)
were removed and the beads were washed three times in lysis buffer.
Pellet and supernatant samples were subjected to electrophoresis on
7.5–15% step-gradient SDS–polyacrylamide gels and blotted onto the
same sheet of Immobilon transfer membrane (Millipore). Ral proteins
were detected by immunoblotting with monoclonal antibody RB9, which
recognizes both RalA and RalB, followed by incubation with an HRP-
conjugated secondary antibody to mouse immunoglobulin (Pierce).
Bands were visualized with enhanced chemiluminescence (Du Pont-
NEN). For quantitation, blots were scanned and evaluated using NIH
Image software. Values of Ral–GTP as a percentage of total Ral protein
were calculated as 100 × [areapellet/(10 × areasup+areapellet)]. For detec-
tion of RalGDS we used monoclonal antibody RG139, which recognizes
both wild-type RalGDS and RalGDS∆RID. Ras was detected with anti-
pan Ras antibody (Ab-2) from Oncogene Research Products.
Supplementary material
Additional methodological detail and a schematic diagram of Ca2+-
dependent pathways that may activate Ral are published with this
paper on the internet.
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Materials and methods
Construction of plasmids
Mammalian expression plasmids were constructed as follows. The
coding sequence of rat RalGDSb [S1] was subcloned as a BamHI–SalI
fragment into a modified Bluescript vector to attach a Kozak consensus
sequence 5′ to the initiation codon. The RalGDS∆RID mutant which
lacks the entire Ras-interacting domain was generated by isolating a
BamHI–PstI fragment containing the first 765 codons and ligating it into
the modified vector; an in-frame stop codon was created by cleavage of
the DNA with EcoRI, blunting with Klenow DNA polymerase and diges-
tion with NotI, generating a fragment that was then ligated into pBlue-
script that had been cleaved with BamHI, blunted with Klenow
polymerase and digested with NotI. Using the polymerase chain reac-
tion (PCR) the coding sequence of RalB was amplified from pET5c-
RalB (obtained from R. Weinberg) with a 5′ oligonucleotide encoding a
Kozak recognition site and the fragment was subcloned into pBlue-
script. The Ral mutants RalS28N and RalQ72L were constructed using the
PCR [S2]. All constructs were verified by dideoxy sequencing and/or
restriction digest and subsequently inserted as NotI–SalI fragments into
the expression plasmid pMT3 [3]. A plasmid that expresses activated
Ras, pDCR-RasG12V [S3], was obtained from M. White. To express the
RasQ61L mutant under control of a tetracycline-repressible promoter, the
coding sequence of RasQ61L was excised from pZIP-RasH(Q61) [S4]
by digestion with BamHI and inserted into pUHG10-3 [S5] (obtained
from M. Gossen), to generate pUHG-rasQ61L. Plasmids encoding GST
fusion proteins were constructed as follows: pGEX-RalB was generated
by subcloning the RalB coding sequence as a BamHI–SalI fragment
into pGEX-KG [S6]. To obtain pGEX-RalGDS(658C) a SacI fragment
containing the final 238 codons of RalGDSb was subcloned into pGEX-
KG. A SacI fragment containing the Ral-binding domain of RIP1 was
isolated from pEXlox-RIP1 [8] and inserted into pGEX-KG to generate
pGEX-RIP. The GST–GNH construct, which contains the Ras-binding
domain of c-Raf1 has been described [17].
Generation of cell lines
The R2-N17 cell line which expresses the dominant-negative RasS17N
mutant under the control of the metal-inducible metallothionein pro-
moter has been described [16]. We used the system described by
Gossen and Bujard [S5] to generate a Rat-2 cell line which expresses
activated RasQ61L under the control of a tetracycline-repressible pro-
motor. Rat-2 cells were transfected with pUHD15-1neo (encoding the
transactivator protein) by electroporation and clones were selected in
medium containing G418. Several clones were screened by transient
transfection with a luciferase reporter (pUHC13-3) and one clone was
expanded into the cell-line R2tTA. To generate the R2tTA-Q61L cell
line, R2tTA cells were co-transfected by electroporation with pUHG-
rasQ61L and a plasmid encoding a puromycin-resistance marker.
Protein purification and monoclonal antibodies
GST fusion proteins were expressed in Escherichia coli. Cells were sus-
pended in phosphate buffered saline (PBS; 140 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) containing a protease
inhibitor cocktail and lysed by sonication. Insoluble material was removed
by centrifugation at 10,000 × g. Triton X-100 was added to 1%
(volume : volume) and proteins were purified by adsorption to glu-
tathione–Sepharose beads. The resin was washed by three cycles of
centrifugation at 1000 × g and re-suspension in PBS. The protein
content was estimated by SDS–PAGE followed by Coomassie staining
using BSA as standard. For generation of monoclonal antibodies, soluble
antigen was obtained by cleaving GST–RalB and GST–RalGDS(658C)
with thrombin (0.1% weight : weight) and removing the resin by centrifu-
gation. Balb/c mice were immunized with purified proteins in Ribi adju-
vant (RIBI ImmunoChem). Splenocytes were fused to Ag653B myeloma
cells and antigen-specific hybridomas were established according to
standard protocols.
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Supplementary material
Figure S1
Model of signal transduction pathways required for Ral activation
following receptor stimulation. Our data demonstrate a major role for a
PLC-dependent increase in intracellular Ca2+ in Ral activation. The
mechanisms by which Ca2+ mobilization leads to activation of Ral are
speculative. Ral contains a calmodulin (CaM)-binding domain [24] and
RalGDS has been shown to be a phosphoprotein [S1], suggesting two
possible mechanisms for Ral activation that are not mutually exclusive.
First, binding of calmodulin to Ral could activate the GTPase either
directly, by an as yet unknown mechanism, or by making the GTPase
more responsive to the activity of RalGDS. Alternatively, phosphorylation
of RalGDS by CaMK-II could activate the catalytic activity of the
exchanger, leading to an increase in Ral nucleotide exchange. The roles
of activated Ras could be equally diverse: Ras may provide a targeting
function and increase the local concentration of RalGDS at the
membrane, it could activate RalGDS directly, or it could act in concert
with CaMK-II and facilitate phosphorylation of the exchanger.
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